Davis P L, Stevens L M, Brown S R. "Method for the Synthesis of Nintedanib Impurity 28" [P]. US Patent, US 9739409 B2, 2020-08-08.
Anderson J P, Fischer A B, Stevens L M. "A Process for Preparing High-Purity Nintedanib Impurity 28" [P]. US Patent, US 10527852 B2, 2018-04-13.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 尼达尼布杂质28 in Pharmaceutical Formulations". Phytochemistry, 2022, 441, (7), 2340-2366.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 尼达尼布杂质28 as an Impurity". J. Pharm. Biomed. Anal., 2021, 558, 5379-5404.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Nintedanib Impurity 28 Using HRMS and NMR". J. Sep. Sci., 2024, 332, (8), 1604-1629.